Entourage Health Corp. (ENTG.V)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.15 CAD | 62.5% |
| 2022 | -0.40 CAD | -25.0% |
| 2021 | -0.32 CAD | 25.58% |
| 2020 | -0.43 CAD | -380.45% |
| 2019 | -0.09 CAD | -940.7% |
| 2018 | -0.01 CAD | 94.27% |
| 2017 | -0.15 CAD | -56.58% |
| 2016 | -0.10 CAD | -196.59% |
| 2015 | -0.03 CAD | 54.38% |
| 2014 | -0.07 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.03 CAD | -64.22% |
| 2024 Q1 | -0.02 CAD | 63.38% |
| 2023 FY | - CAD | 62.5% |
| 2023 Q1 | -0.03 CAD | 89.28% |
| 2023 Q4 | -0.06 CAD | -72.98% |
| 2023 Q2 | -0.03 CAD | -0.32% |
| 2023 Q3 | -0.03 CAD | -3.21% |
| 2022 Q2 | -0.03 CAD | -3.13% |
| 2022 Q3 | -0.06 CAD | -92.93% |
| 2022 FY | - CAD | -25.0% |
| 2022 Q1 | -0.03 CAD | 83.06% |
| 2022 Q4 | -0.29 CAD | -406.11% |
| 2021 FY | - CAD | 25.58% |
| 2021 Q3 | -0.08 CAD | -84.67% |
| 2021 Q4 | -0.17 CAD | -104.57% |
| 2021 Q2 | -0.04 CAD | -36.36% |
| 2021 Q1 | -0.03 CAD | 91.54% |
| 2020 Q3 | 0.04 CAD | 195.14% |
| 2020 Q4 | -0.39 CAD | -1048.91% |
| 2020 Q1 | -0.04 CAD | 27.86% |
| 2020 Q2 | -0.04 CAD | 3.57% |
| 2020 FY | - CAD | -380.45% |
| 2019 Q3 | -0.12 CAD | -209.09% |
| 2019 Q1 | -0.02 CAD | 70.69% |
| 2019 Q2 | 0.11 CAD | 609.26% |
| 2019 Q4 | -0.06 CAD | 48.25% |
| 2019 FY | - CAD | -940.7% |
| 2018 Q2 | -0.02 CAD | -22.46% |
| 2018 FY | - CAD | 94.27% |
| 2018 Q4 | -0.07 CAD | -181.89% |
| 2018 Q3 | 0.09 CAD | 632.54% |
| 2018 Q1 | -0.01 CAD | 56.19% |
| 2017 Q2 | -0.08 CAD | -157.54% |
| 2017 FY | - CAD | -56.58% |
| 2017 Q4 | -0.03 CAD | -250.0% |
| 2017 Q1 | -0.03 CAD | 42.07% |
| 2017 Q3 | -0.01 CAD | 89.25% |
| 2016 Q1 | -0.01 CAD | 72.97% |
| 2016 Q4 | -0.06 CAD | -439.42% |
| 2016 Q3 | -0.01 CAD | 56.3% |
| 2016 Q2 | -0.02 CAD | -296.67% |
| 2016 FY | - CAD | -196.59% |
| 2015 Q3 | -0.00 CAD | 82.35% |
| 2015 FY | - CAD | 54.38% |
| 2015 Q2 | -0.00 CAD | 45.16% |
| 2015 Q1 | -0.01 CAD | 0.0% |
| 2015 Q4 | -0.02 CAD | -3600.0% |
| 2014 Q3 | -0.01 CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| 2014 Q4 | - CAD | 100.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | -0.02 CAD | -569.643% |
| CanadaBis Capital Inc. | 0.03 CAD | 562.963% |
| Decibel Cannabis Company Inc. | -0.00 CAD | -3388.372% |
| Delivra Health Brands Inc. | 0.00 CAD | 4938.71% |
| Lifeist Wellness Inc. | -0.58 CAD | 74.138% |
| Cannara Biotech Inc. | 0.08 CAD | 292.802% |
| Medicure Inc. | -0.09 CAD | -69.875% |
| PharmaCielo Ltd. | -0.10 CAD | -50.0% |
| Rubicon Organics Inc. | -0.03 CAD | -364.396% |
| BioSyent Inc. | 0.54 CAD | 127.778% |
| Voyageur Pharmaceuticals Ltd. | -0.01 CAD | -1301.869% |